Japan is experiencing an ongoing shortage of generic medicines due to a string of scandals and other structural problems, hindering efforts to combat the flu.
Out of over 16,000 pharmaceutical products, 3,103 — or 18.5% — were either in limited or suspended supply as of the end of October, according to a survey conducted by the Federation of Pharmaceutical Manufacturers’ Associations of Japan.
Over 60% of these are generic drugs, which include treatments for fever, cough and other flu-like symptoms. With the health ministry declaring the start of this year’s flu season on Nov. 8, demand for such medicine is rising.
With your current subscription plan you can comment on stories. However, before writing your first comment, please create a display name in the Profile section of your subscriber account page.